Personalis Launches the ACE Clinical Exome™

Personalis introduces the first test to combine an enhanced clinical exome with genome-wide structural variant detection.

Menlo Park, CA – Personalis, Inc., the leading provider of advanced medical exome and genome sequencing and interpretation services today announced the launch of an early access program to the Personalis ACE Clinical Exome™, a single test that integrates enhanced exome sequencing with genome-wide structural variant detection to increase diagnostic yield. “Personalis’ goal is to improve diagnostic yield while decreasing overall cost and turnaround time compared with traditional serial genetic testing. Until now separate testing has been required for exome-wide small variant detection and genome-wide structural variant detection” said Personalis’ CEO John West “Our ACE Clinical Exome replaces this serial genetic testing approach with a single, convenient test”.